bace 1 inhibitor iv (calbiochem iv) (Millipore)
Structured Review
Bace 1 Inhibitor Iv (Calbiochem Iv), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bace-1+inhibitor+iv/anti+bace1/pmc11341970-405-0-4
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents Article Snippet: Article Title: Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors. Article Snippet: Alkaloids have always been a great source of cholinesterase inhibitors.. Numerous studies have shown that inhibiting acetylcholinesterase as well as butyrylcholinetserase is advantageous, and have better chances of success in preclinical/ clinical settings.. With the objective to discover dual cholinesterase inhibitors, herein we report synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine (1) and its bromo-derivative 2. Article Title: Macrocyclic statine-based inhibitors of BACE-1. Article Snippet: Proteolysis of the membrane-anchored amyloid precursor protein (APP) leads to the Ab peptide, which accumulates in the brain, forming insoluble plaques and neurofibrillary tangles as the key pathological features of Alzheimer’s disease.. Clear evidence that the aspartyl protease BACE-1 (b-secretase) is mainly responsible for the generation of the Ab peptide makes inhibition of this protease an attractive therapeutic target for the treatment and prevention of Alzheimer’s disease.. The first generation of BACE-1 inhibitors were substrate analogues in which the scissile amide bond was replaced with a noncleavable isostere of the statine or hydroxyethylene type. Article Title: Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents Article Snippet: Article Title: Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent. Article Snippet: Funding information Council of Scientific and Industrial Research (CSIR, India), Grant/Award Number: P90807 (CSIR Young Scientist Award Grant) Abstract Beta-secreatse (BACE-1) and cholinesterases are clinically validated targets of Alzheimer's disease (AD), for which natural products have provided immense contribution.. The multifaceted nature of AD signifies the need of multitargeted agents to tackle this disease.. In the search of new natural products as dual BACE-1/cholinesterase inhibitors, a library of pure natural products was screened for inhibition of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and BACE-1. Article Title: Multifunctional agents against Alzheimer's disease based on oxidative stress: Polysubstituted pyrazine derivatives synthesized by multicomponent reactions. Article Snippet: As Alzheimer’s disease (AD) is a neurodegenerative disease with a complex pathogenesis, the exploration of multi-target drugs may be an effective strategy for AD treatment.. Multifunctional small molecular agents can be obtained by connecting two or more active drugs or privileged pharmacophores by multicomponent reactions (MCRs).. In this paper, two series of polysubstituted pyrazine derivatives with multifunctional moieties were designed as anti-AD agents and synthesized by Passerini-3CR and Ugi-4CR. Article Title: Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site Article Snippet: As control, Article Title: Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents. Article Snippet: Design, synthesis and biological evaluation of 1benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer’s agents Dawid Panek, Anna Wi#ckowska, Jakub Jo#czyk, Justyna Gody#, Marek W. Bajda, Tomasz Wichur, Anna Pasieka, Damijan Knez, Anja Pislar, Jan Korabecny, Ondrej Soukup, Vendula Sepsova, Raimon Sabaté, Janko Kos, Stanislav Gobec, and Barbara Malawska |
a " width="250" height="auto" />
a " width="100%" height="100%">
a " width="100%" height="100%">